As the US Food and Drug Administration continues documenting recalls of OTC and Rx drugs containing the antacid ranitidine, a Capitol Hill critic of the agency is urging it to keep the ingredient off the market.
Rep
DeLauro Renews Push To Give FDA Mandatory Recall Authority For Drugs
"FDA’s failure to stop companies from selling ranitidine makes the United States government complicit in exposing infants and adults to the risk of cancer," says Rep. DeLauro in letter to FDA and HHS. She also re-introduced legislation proposing FDA have mandatory recall authority for drugs.
